Frontiers in Nutrition (May 2022)
Prognostic Roles of Glucose to Lymphocyte Ratio and Modified Glasgow Prognosis Score in Patients With Non-small Cell Lung Cancer
- Ming Yang,
- Ming Yang,
- Ming Yang,
- Qi Zhang,
- Qi Zhang,
- Qi Zhang,
- Yi-Zhong Ge,
- Yi-Zhong Ge,
- Yi-Zhong Ge,
- Yi-Zhong Ge,
- Meng Tang,
- Meng Tang,
- Meng Tang,
- Chun-Lei Hu,
- Chun-Lei Hu,
- Chun-Lei Hu,
- Zi-Wen Wang,
- Zi-Wen Wang,
- Zi-Wen Wang,
- Xi Zhang,
- Xi Zhang,
- Xi Zhang,
- Meng-Meng Song,
- Meng-Meng Song,
- Meng-Meng Song,
- Guo-Tian Ruan,
- Guo-Tian Ruan,
- Guo-Tian Ruan,
- Xiao-Wei Zhang,
- Xiao-Wei Zhang,
- Xiao-Wei Zhang,
- Tong Liu,
- Tong Liu,
- Tong Liu,
- Hai-Lun Xie,
- Hai-Lun Xie,
- Hai-Lun Xie,
- He-Yang Zhang,
- He-Yang Zhang,
- He-Yang Zhang,
- Kang-Ping Zhang,
- Kang-Ping Zhang,
- Kang-Ping Zhang,
- Qin-Qin Li,
- Qin-Qin Li,
- Qin-Qin Li,
- Xiang-Rui Li,
- Xiang-Rui Li,
- Xiang-Rui Li,
- Xiao-Yue Liu,
- Xiao-Yue Liu,
- Xiao-Yue Liu,
- Shi-Qi Lin,
- Shi-Qi Lin,
- Shi-Qi Lin,
- Shi-Qi Lin,
- Han-Ping Shi,
- Han-Ping Shi,
- Han-Ping Shi
Affiliations
- Ming Yang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Ming Yang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Ming Yang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Qi Zhang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Qi Zhang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Qi Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Yi-Zhong Ge
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Yi-Zhong Ge
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Yi-Zhong Ge
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Yi-Zhong Ge
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
- Meng Tang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Meng Tang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Meng Tang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Chun-Lei Hu
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Chun-Lei Hu
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Chun-Lei Hu
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Zi-Wen Wang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Zi-Wen Wang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Zi-Wen Wang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Xi Zhang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xi Zhang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Xi Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Meng-Meng Song
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Meng-Meng Song
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Meng-Meng Song
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Guo-Tian Ruan
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Guo-Tian Ruan
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Guo-Tian Ruan
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Xiao-Wei Zhang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xiao-Wei Zhang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Xiao-Wei Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Tong Liu
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Tong Liu
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Tong Liu
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Hai-Lun Xie
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Hai-Lun Xie
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Hai-Lun Xie
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- He-Yang Zhang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- He-Yang Zhang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- He-Yang Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Kang-Ping Zhang
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Kang-Ping Zhang
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Kang-Ping Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Qin-Qin Li
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Qin-Qin Li
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Qin-Qin Li
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Xiang-Rui Li
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xiang-Rui Li
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Xiang-Rui Li
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Xiao-Yue Liu
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xiao-Yue Liu
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Xiao-Yue Liu
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Shi-Qi Lin
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Shi-Qi Lin
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Shi-Qi Lin
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Shi-Qi Lin
- The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
- Han-Ping Shi
- Department of Gastrointestinal Surgery / Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Han-Ping Shi
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China
- Han-Ping Shi
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- DOI
- https://doi.org/10.3389/fnut.2022.871301
- Journal volume & issue
-
Vol. 9
Abstract
BackgroundNon-small cell lung cancer (NSCLC) is among the most prevalent malignancies worldwide. Previous studies have shown that the status of inflammation, nutrition and immune are closely related to overall survival (OS) of patients with NSCLC, but little is known about their interactive and combined roles. Hence, we chose glucose to lymphocyte ratio (GLR) and modified Glasgow Prognosis Score (mGPS) as prognostic factors and assessed the prognostic values of them for patients with NSCLC.MethodsBaseline clinicopathologic and laboratory characteristics of 862 patients with NSCLC were obtained from a multicenter prospective cohort. The Cox proportional hazard regression models were used to determine prognostic values of the clinical factors. A nomogram was also constructed integrating the clinical factors with clinical significance or independent prognostic values. Concordance index (C-index) was utilized to evaluate the prediction accuracy of the TNM stage and the nomogram.ResultsMultivariate analyses demonstrated that GLR [Hazard ratio (HR) = 1.029, 95% confidence interval (CI) = 1.004–1.056, P = 0.023] and mGPS (score of 1: HR = 1.404, 95% CI = 1.143–1.726, P = 0.001; score of 2: HR = 1.515, 95% CI = 1.159–1.980, P = 0.002) were independent prognostic factors for patients with NSCLC. The C-indexes of the TNM stage and the nomogram were 0.642 (95% CI = 0.620–0.663) and 0.694 (95% CI = 0.671–0.717), respectively.ConclusionGLR and mGPS were independent prognostic factors for patients with NSCLC. Moreover, our constructed nomogram might be superior in predicting prognosis of patients with NSCLC compared with the TNM stage.
Keywords
- glucose to lymphocyte ratio
- modified Glasgow Prognosis Score
- non-small cell lung cancer
- inflammation
- nutrition
- immune